Second Generation Histamine H-1 Antagonists


Terfenadine:
  • high antagonistic selectivity fo H1-receptors
  • non-sedating (poor distribution to CNS)
  • high concentrations - proarrhythmic activity (CYP3A inhibitors can increase proarrhymthmic potential (macrolides, HIV protease inhibitors, SSRI antidepressants, etc.)

Fexofenadine:
  • CYP3A metabolite of terfenadine
  • high antagonistic selectivity fo H1-receptors
  • nonsedating
  • no proarrhythmic properties - fewer drug interactions

Astemizole:
  • long-acting (strong receptor association + long-acting 4-OH metabolite)
  • some antiadrenergic and anti-serotonergic actions
  • nonsedating`
  • proarrhythmic (enhanced when metabolism is inhibited - see terfenadine)

Loratadine
  • carbamate function keeps drug peripherally,
  • anti-ACh and anti-adrenergic activity
  • non-sedating (hydrophilic)
  • descarbethoxy metabolite retains high anti-H1 activity
  • no proarrhythmic activity

Return to: PY421 Home Page